Sinopharm Group Co Ltd
HKEX:1099
Sinopharm Group Co Ltd
Cash from Operating Activities
Sinopharm Group Co Ltd
Cash from Operating Activities Peer Comparison
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Sinopharm Group Co Ltd
HKEX:1099
|
Cash from Operating Activities
¥11.9B
|
CAGR 3-Years
38%
|
CAGR 5-Years
33%
|
CAGR 10-Years
11%
|
|
S
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
Cash from Operating Activities
¥5.2B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
11%
|
CAGR 10-Years
18%
|
Jointown Pharmaceutical Group Co Ltd
SSE:600998
|
Cash from Operating Activities
¥6.3B
|
CAGR 3-Years
15%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
C
|
China National Medicines Corp Ltd
SSE:600511
|
Cash from Operating Activities
¥2.7B
|
CAGR 3-Years
28%
|
CAGR 5-Years
23%
|
CAGR 10-Years
31%
|
Huadong Medicine Co Ltd
SZSE:000963
|
Cash from Operating Activities
¥3.3B
|
CAGR 3-Years
3%
|
CAGR 5-Years
2%
|
CAGR 10-Years
N/A
|
|
C
|
China National Accord Medicines Corp Ltd
SZSE:000028
|
Cash from Operating Activities
¥2.9B
|
CAGR 3-Years
25%
|
CAGR 5-Years
17%
|
CAGR 10-Years
20%
|
See Also
What is Sinopharm Group Co Ltd's Cash from Operating Activities?
Cash from Operating Activities
11.9B
CNY
Based on the financial report for Jun 30, 2023, Sinopharm Group Co Ltd's Cash from Operating Activities amounts to 11.9B CNY.
What is Sinopharm Group Co Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
11%
Over the last year, the Cash from Operating Activities growth was 329%. The average annual Cash from Operating Activities growth rates for Sinopharm Group Co Ltd have been 38% over the past three years , 33% over the past five years , and 11% over the past ten years .